Plaintiffs (or more properly, their lawyers) across the country have been filing no-injury class actions against over-the-counter (“OTC”) drug manufacturers on a variety of cooked-up theories that have little or nothing to do with the safety or efficacy of these drugs. One such theory, that we have discussed several times, is that drugs that the... Continue Reading| Drug & Device Law
A federal judge in California filed an important OTC preemption decision earlier this month, and it’s important because it applied federal preemption to| Drug & Device Law
In 2018, our blogpost on In re Johnson & Johnson Talcum Powder Products Marketing, Sales Practices & Liability Litigation, 903 F.3d 278 (3d Cir.| Drug & Device Law